VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

rB-HPIV3-G1
Vaccine Information
  • Vaccine Name: rB-HPIV3-G1
  • Target Pathogen: Human Respiratory Syncytial Virus
  • Target Disease: Respiratory tract disease
  • Type: Recombinant vector vaccine
  • Status: Licensed
  • Host Species for Licensed Use: Hamster
  • Preparation: Recombinant PIV3 expressing the RSV G ORF (Schmidt et al., 2001)
  • Immunization Route: Intramuscular injection (i.m.)
Host Response
References
Schmidt et al., 2001: Schmidt AC, McAuliffe JM, Murphy BR, Collins PL. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3. Journal of virology. 2001; 75(10); 4594-4603. [PubMed: 11312329].